Historically, most patients who required parenteral anticoagulation received heparin,
whereas those patients requiring oral anticoagulation received warfarin. Due to the narrow …

Intracerebral hemorrhage (ICH) refers to primary, spontaneous, nontraumatic bleeding
occurring in the brain parenchyma. ICH accounts for 10% to 20% of all cerebrovascular …

Background: Over the last ten years, a new class of drugs, known as the direct-acting oral
anticoagulants (DOACs), have emerged at the forefront of anticoagulation therapy. Like the …

Intracerebral hemorrhage (ICH) is the most dangerous complication of oral anticoagulant
treatment (OAT). Up to half of patients with OAT-related ICH experience early clinical …

Pulmonary embolism (PE) is a common and potentially lethal form of venous
thromboembolic disease in ICU patients. A limited number of risk factors have been …

Abstract Dabigatran etexilate (Pradaxa®, Prazaxa®) has recently been approved for the
treatment of acute venous thromboembolism (VTE) and prevention of VTE recurrence …

Opinion statement Direct oral anticoagulants (DOAC) are an attractive therapeutic option for
anticoagulant treatment in the setting of venous thromboembolism or non-valvular atrial …

Therapeutic interventions unique to the neuroradiology suite include the endovascular
treatment of cerebral aneurysms, arteriovenous malformations (AVM), acute thromboembolic …

OBJECTIVE: This article serves as a resource for health care professionals by providing a
summary of primary literature and guidelines for use of the available oral anticoagulant …

Thromboembolic disorders are among the leading causes of morbidity and mortality in Iran.
Anticoagulation therapy of affected patients is achieved using a variety of agents, including …